Cambridge Isotope Laboratories, Inc. (CIL) board of directors appointed Cliff Caldwell as its new chief executive officer (CEO), as Joel Bradley, founder and CEO, stepped down from his position after 38 years.

New reports evaluate the economic feasibility of chemicals manufacturing through alternative, bio-based routes